Pfizer

学者数788

论文数249

被引数0

关联论文 (246)

发表时间

Perspective on Pharmacokinetic Comparability for Biologics Development 生物药开发中药物动力学可比性的展望

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2026-09-18

PREAI

Fei Tang; Yifei Zhang; Mohamed Elmeliegy; Janki Mihir Desai; Yow-Ming Wang; Zhenhua Xu

Final Biomarker and Efficacy Analyses of Lorlatinib in Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer in a Phase 2 Study 洛拉替尼在II期研究中对ALK阳性晚期非小细胞肺癌患者的最终生物标志物和疗效分析

Journal of Thoracic Oncology

IF20.8

2026-09-17

PREAI

Todd M. Bauer; Jean-François Martini; Benjamin Besse; Chia-Chi Lin; Ross A. Soo; Gregory J. Riely; I-Ming Wang; Francesca Toffalorio; Deborah A. Shepard; Tiziana Usari (; Phineas Hamilton (; D. Ross Camidge; Steven Kao; Rita Chiari; Shirish Gadgeel; Enriqueta Felip; Alice T. Shaw; Benjamin J. Solomon

Pharmaceutical Industry Perspectives on Exposure-Response Confounding in Large Molecule Therapeutics: Results From an IQ Consortium Survey 制药行业对大分子治疗药物中暴露-反应混杂因素的观点：IQ联盟调查结果

CPT-Pharmacometrics & Systems Pharmacology

IF3

2026-09-16

OAAI

Engie Salama; Manisha Lamba; Sihem Ait-Oudhia; Ellen Wang; Dorothee Semiond; Zhang Li; Tao Long; Satyendra Suryawanshi; Leticia Arrington; Wei Gao; Xiaowen Guan; Hugh Giovinazzo; Dale Miles; David C. Turner

Patient Preferences for the Treatment of Haemophilia A and B in France 法国患者对A型和B型血友病治疗的偏好

Haemophilia

IF3

2026-09-16

OAAI

Yesim Dargaud; Yasmine Fahfouhi; Monia Ezzalfani; Astrid Foix Colonier; Alaeddine Sidhom; Aline Gauthier; Jérémie Rudant; Meriem Kessouri; Nicolas Giraud; Benoît Guillet; Anaïs Reynaud

AI-Enabled Early Intracranial Volumetric Response Predicts Systemic Progression Free Survival in the Phase III CROWN Study 人工智能赋能的早期颅内体积反应预测III期CROWN研究中系统性无进展生存期

Neuro-Oncology Advances

IF4.1

2026-09-07

OAAI

Shao-Lun Lu; Yu-Cheng Chang; Chih-Hung Liang; Po-Lin Chiang; Kevin Maresca; Erqi Pollom; Keith Wilner; Jen-Tang Lu; Francesca Toffalorio; Giuseppe Giaccone; Chong Duan

A Randomized Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Bivalent RSVpreF Vaccine in Older Adults in Korea 一项随机III期研究，旨在评估韩国老年人中二价RSVpreF疫苗的安全性、耐受性和免疫原性

Vaccines

IF3.4

2026-09-03

OAAI

Won Suk Choi; Karen Quan; James A. Baber; Anna Jaques; Karla Janse van Rensburg; Wen Li; Mark W. Cutler; Elena V. Kalinina; Annaliesa S. Anderson; Kena A. Swanson; Alejandra Gurtman

The Impact of Respiratory Syncytial Virus Undertesting on Estimates of Disease Burden and Vaccine Effectiveness in a Large Integrated Healthcare System 呼吸道合胞病毒检测不足对大型整合医疗系统中疾病负担和疫苗效果估计的影响

Open Forum Infectious Diseases

IF3.8

2026-09-02

OAAI

Bradley K Ackerson; Brandon Chia; Negar Aliabadi; Gabriella Goodwin; Jeff Slezak; Vennis Hong; Qing Liu; Sally Shaw; Sabrina Welsh; Julie A Stern; Banshri Kapadia; Brigitte C Spence; Joseph A Lewnard; Gregg Davis; Evan J Zasowski; Michael Aragones; Ashley Miller; Michael Dutro; Erica Chilson; Elisa Gonzalez; Robin Hubler; Luis Jodar; Bradford D Gessner; Elizabeth Begier; Sara Y Tartof; null

Cost-Effectiveness Analysis of Older Adult Vaccination with the Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine in Mexico 墨西哥使用二价呼吸道合胞病毒预融合F蛋白（RSVpreF）疫苗进行老年人疫苗接种的成本效益分析

Vaccines

IF3.4

2026-08-30

OAAI

Veronica Guajardo; Ali Shajarizadeh; Nishu Gaind; Luka Ivkovic; Rengina Kefalogianni; Diana Mendes

Collaborative functionality between three types of inflammation in idiopathic pulmonary fibrosis 特发性肺纤维化中三种炎症类型之间的协同功能

Nature Immunology

IF27.6

2026-08-21

PREAI

Thomas Fabre; Thomas A. Wynn; Kevin M. Hart

Lipophilic Salts of High Melting Point Drugs Modulate Solid-State Properties and Organic Solubility to Enable Manufacturability of Amorphous Solid Dispersions 高熔点药物的脂溶性盐调节固体状态性质和有机溶解度以实现非晶态固体分散体的可制造性

ORGANIC PROCESS RESEARCH & DEVELOPMENT

IF3.5

2026-08-21

PREAI

Stella P. Petrova; Matthew M. Behymer; Naga K. Duggirala; Aaron Goodwin; Dana E. Moseson-Tarrh; Lynne S. Taylor

Photoproximity labeling of c-Myc reveals SLK as a cancer-specific co-regulator 光邻近标记c-Myc揭示了SLK作为癌症特异性共调控因子

Nature Chemical Biology

IF13.7

2026-08-13

OAAI

Ryan R. Milione; Feifei Tong; Kelsey L. Wolfe; Cameron J. Douglas; Sara B. Linker; Xinmeng Jasmine Mu; James V. Oakley; Andrew R. Nager; Michalina Janiszewska; Ciaran P. Seath

Condition-Specific LC Retention Time Prediction: Feature-Selected QSRR Versus Pretrained Graph Isomorphism Network Transfer Learning 条件特异性液相色谱保留时间预测：特征选择的QSRR与预训练图同构网络迁移学习

International Journal of Molecular Sciences

IF4.9

2026-08-11

OAAI

Roman Szucs; Emília Sýkorová; Iveta Boháčová; Ilaria Neri; Lucy M. Morgan; Merisa Moriarty; Melissa Hanna-Brown

Clinical Pharmacology at the Point of Decision 决策点的临床药理学

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2026-08-11

OAAI

Mohamed Elmeliegy; Avery McIntosh

A quantitative computational framework for particle descriptors of pharmaceutical compounds 一种用于药物化合物粒子描述符的定量计算框架

Powder Technology

IF4.6

2026-08-06

OAAI

Alexandru A. Moldovan; Cheryl L. Doherty; Helen Blade; Shubham Sharma; Rajni Miglani Bhardwaj; Andrew G.P. Maloney

Assessing Local Experiences of Health Phenomena: A Methodology for Social Media Surveillance in Public Health 评估健康现象的本地经验：一种公共卫生社交媒体监测的方法论

International Journal of Qualitative Methods

IF3.8

2026-08-04

PREAI

Paula Kibuka Musoke; Lori Frohwirth; María C. Baquero; L. Hannah Gould

Post-Treatment Lyme Disease Syndrome in Six European Countries Using Data from the Burden of Lyme Disease (BOLD) Study 欧洲六国使用“莱姆病负担”（BOLD）研究数据探讨莱姆病后综合症

Pathogens

IF3.3

2026-08-02

OAAI

Holly Yu; Amanda R. Mercadante; Kate Halsby; Alexandra Loew-Baselli; Ye Tan; Frederick J. Angulo; Elizabeth Begier; Mendwas Dzingina; Johan S. Berglund; Anna Moniuszko-Malinowska; Viliam Cibik; Dagmar Zakova; Franc Strle; James H. Stark; on behalf of the BOLD Study Group

Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting report 疫苗效力和许可的III期临床试验替代方案：真实世界证据的作用——会议报告

Biologicals

IF1.5

2026-08-01

OAAI

de Moerlooze, Laurence; Allen, Alexander; Bartalesi, Ilaria; Cavaleri, Marco; Davenport, Miles P.; Gessner, Bradford D.; Gomes, Brenda; Hayford, Kyla; Izu, Alane; Izurieta, Hector S.; Jenkins, Victoria A.; Kastner, Randee; Krause, Phil; Nealon, Joshua; Oostvogels, Lidia; Palmu, Arto A.; Read, Robert C.; Saenz, Carla; Smith, Dean K.; Tuboi, Suely; Vandendriessche, Frank; Baay, Marc; Craig, Danielle; Neels, Pieter; Bollaert, Kaatje

Alopecia Areata Prevalence in Australia: Insights From a Nationally Representative Cross-Sectional Survey Study 斑秃在澳大利亚的患病率：一项全国代表性横断面调查研究的见解

Australasian Journal of Dermatology

IF1.8

2026-08-01

OAAI

Sinclair, Rodney; Eisman, Samantha; Yip, Leona; Hitschfeld, Maureen; Williamson, Anna; Stratton, Giles; Lohan, Christoph; Lee, Carol M. Y.; Kapoor, Komal; Pereira, Candida da Fonseca

Catalytic Appel fluorination of alcohols with potassium fluoride 以氟化钾为催化剂的醇类Appel氟化反应

Science

IF45.8

2026-07-30

PREAI

Anirban Mondal; Job J. C. Struijs; Caleb J. N. Doyle; Zijun Chen; Zian Wang; Worawit Tangamornchaipattana; Christophe Allais; Paul F. Richardson; Jared Piper; Robert S. Paton; Simon Aldridge; Véronique Gouverneur

Budget impact analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccination for preventing respiratory syncytial virus in Egyptian infants 埃及婴儿呼吸道合胞病毒二价前融合F蛋白（RSVpreF）母体疫苗接种的成本影响分析

Human Vaccines & Immunotherapeutics

IF0

2026-07-28

OAAI

Ahmed El Hag; Nardine Nabil; Rowan El Masry; Elsayed Elbadawy Awad; Eman Mahmoud Fouda; Moataza Bashir Hamed; Yasser Abou Talib; Amy Law; Diana Mendes; Mohamed Aladdin